What to know before starting online TRT

On 19 September 2026 we looked for one thing across all 32 clinics we rank: a named, identifiable licensed clinician commenting on that specific clinic, in a published and attributable source. A medical journal, a named physician quoted in reputable press, or a clinic's own named clinical staff making a substantive statement. We found none. Not one clinic, out of 32.

What exists instead: 8 clinics name their own clinical leadership, which is the clinic describing itself. Two carry a “medically reviewed by” byline on their own copy. One advertises “glowing endorsements from leading dermatologists” and lists four board-certified names without publishing a single statement from any of them. The remaining 21 name no clinician at all.

Commentary on this category does exist, and it is not reassuring. But it is about direct-to-consumer testosterone clinics as a class, not about any clinic by name. Dr. Bradley Anawalt, who has led the Hormone Health Network, has called low-T clinics “sex hormone factories”. A JAMA Internal Medicine secret-shopper study (Dubin, Jesse, Fantus et al., 2022) found most of seven platforms ready to prescribe to a patient with normal testosterone. And identified them only as “Platform 1” through “Platform 7”, so not even that study can be attached to a clinic by name.

We are publishing the absence rather than filling it. We did not build a physician-commentary section, because it would render for zero clinics, and the only way to make it render would be to accept the sources we exclude on purpose: forums, review sites, affiliate blogs, anonymous or self-claimed credentials. An empty result is a result.